Latest Imugene News & Updates

See the latest news and media coverage for Imugene. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Imugene

Clinical-stage immuno-oncology company

imugene.com
Headquarters
Sydney, Australia
Founded year
2013
Company type
Public company
Number of employees
50–200
Industry
Biotechnology & Medical Research

Last updated

Latest news about Imugene

In short: Imugene reported high response rates for its azer-cel therapy, secured several funding rounds, and saw its long-serving CEO resign.

Company announcements

Imugene

Imugene's azer-cel gets FDA fast track, 100% CLL response

The FDA granted fast track for CLL/SLL and MZL. Updated ASCO data showed 83% MZL and 100% CLL response rates. First patient dosed in BTKi combo cohort.

Unlock all announcements with a

Media coverage

Sharecafe

Imugene Secures $11.1 Million Placement to Propel Azer-cel Development

The capital raise, following positive early clinical data, will fund the lead asset through key milestones and extend operations into 2027. Imugene Limited (ASX: IMU...

Unlock all articles with a

Never miss news about Imugene

Track Imugene and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Imugene competitors & trending companies

Browse news for competitors to Imugene and other trending companies.